Immunocompromised people with persistent COVID infections can harbor drug-resistant variants of the virus, which have the potential to spread, researchers at Weill Cornell Medicine, the College of Veterinary Medicine and the NIH have found.
A study from Weill Cornell Medicine provides new insights into a pair of proteins and their opposing functions in regulating the interferon response in hepatic stellate cells, a critical immune component in the liver’s fight against tumors.
Visiting AAP NYC architecture faculty Shin and Rich of the Newark, New Jersey-based firm HECTOR share thoughts on democratizing urban design and how they have learned from the US tradition of popular education.
By repeatedly scanning the brains of a small group of patients for a year and a half, Weill Cornell Medicine researchers have identified a distinct pattern of neuronal interactions that appears to predispose some people to developing depression.
The newest episode of “Startup Cornell,” a podcast hosted by Entrepreneurship at Cornell, features Josh Gully ’83, managing director of NewEdge Wealth.
For his support in helping the Cornell Program in Infrastructure Policy access critical funding in his role as vice provost, Emmanuel Giannelis received the program's annual award during a ceremony in New York City.
After sampling food markets in Chinatown districts, Cornell researchers found evidence that some threatened species of sea cucumbers – a pricey, nutritious delicacy – get sold to consumers.
A new study from Weill Cornell Medicine researchers helps explain why having ApoE4 – the gene variant most closely linked to Alzheimer’s disease – increases the risk of neurodegeneration and white matter damage.
About half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a report from Weill Cornell Medicine and Dana-Farber Cancer Center investigators.